Display options
Cite
Kogiso M, Qi L, Lindsay H, et al. Xenotransplantation of pediatric low grade gliomas confirms the enrichment of . Oncotarget. 2017;8(50):87455-87471doi: 10.18632/oncotarget.20713.
Kogiso, M., Qi, L., Lindsay, H., Huang, Y., Zhao, X., Liu, Z., Braun, F. K., Du, Y., Zhang, H., Bae, G., Zhao, S., Injac, S. G., Sobieski, M., Brunell, D., Mehta, V., Tran, D., Murray, J., Baxter, P. A., Yuan, X. J., Su, J. M., Adesina, A., Perlaky, L., Chintagumpala, M., Parsons, D. W., Lau, C. C., Stephan, C. C., Lu, X., & Li, X. N. (2017). Xenotransplantation of pediatric low grade gliomas confirms the enrichment of . Oncotarget, 8(50), 87455-87471. https://doi.org/10.18632/oncotarget.20713
Kogiso, Mari, et al. "Xenotransplantation of pediatric low grade gliomas confirms the enrichment of ." Oncotarget vol. 8,50 (2017): 87455-87471. doi: https://doi.org/10.18632/oncotarget.20713
Kogiso M, Qi L, Lindsay H, Huang Y, Zhao X, Liu Z, Braun FK, Du Y, Zhang H, Bae G, Zhao S, Injac SG, Sobieski M, Brunell D, Mehta V, Tran D, Murray J, Baxter PA, Yuan XJ, Su JM, Adesina A, Perlaky L, Chintagumpala M, Parsons DW, Lau CC, Stephan CC, Lu X, Li XN. Xenotransplantation of pediatric low grade gliomas confirms the enrichment of . Oncotarget. 2017 Sep 08;8(50):87455-87471. doi: 10.18632/oncotarget.20713. eCollection 2017 Oct 20. PMID: 29152094; PMCID: PMC5675646.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2017 Sep 08;8(50):87455-87471. doi: 10.18632/oncotarget.20713. eCollection 2017 Oct 20.

Xenotransplantation of pediatric low grade gliomas confirms the enrichment of .

Oncotarget

Mari Kogiso, Lin Qi, Holly Lindsay, Yulun Huang, Xiumei Zhao, Zhigang Liu, Frank K Braun, Yuchen Du, Huiyuan Zhang, Goeun Bae, Sibo Zhao, Sarah G Injac, Mary Sobieski, David Brunell, Vidya Mehta, Diep Tran, Jeffrey Murray, Patricia A Baxter, Xiao-Jun Yuan, Jack M Su, Adekunle Adesina, Laszlo Perlaky, Murali Chintagumpala, D Williams Parsons, Ching C Lau, Clifford C Stephan, Xinyan Lu, Xiao-Nan Li

Affiliations

  1. Department of Pediatrics, Baylor College of Medicine, Texas Children's Cancer Center, Texas Children's Hospital, Houston, TX, USA.
  2. Department of Neurosurgery, The First Affiliated Hospital, Soochow University, Suzhou, China.
  3. Department of Ophthalmology, First Affiliated Hospital of Harbin, Medical University, Harbin, China.
  4. Department of Radiotherapy, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  5. Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M College of Medicine, Houston, TX, USA.
  6. Department of Pathology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
  7. Department of Hematology and Oncology, Cook Children's Medical Center, Fort Worth, TX, USA.
  8. Department of Hematology and Oncology, Xinhua Children's Hospital, Shanghai, China.
  9. Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

PMID: 29152094 PMCID: PMC5675646 DOI: 10.18632/oncotarget.20713

Abstract

To identify cellular and molecular changes that driver pediatric low grade glioma (PLGG) progression, we analyzed putative cancer stem cells (CSCs) and evaluated key biological changes in a novel and progressive patient-derived orthotopic xenograft (PDOX) mouse model. Flow cytometric analysis of 22 PLGGs detected CD133

Keywords: BRAF V600E; CDKN2A; cancer stem cell; low grade glioma; orthotopic xenograft

Conflict of interest statement

CONFLICTS OF INTEREST There is no conflict of interests for any author.

References

  1. Cancer Cell. 2006 Dec;10 (6):454-6 - PubMed
  2. Acta Neuropathol. 2016 Jun;131(6):803-20 - PubMed
  3. Neuro Oncol. 2010 Jun;12(6):580-94 - PubMed
  4. Exp Cell Res. 2007 Jun 10;313(10):2050-62 - PubMed
  5. Cancer. 2016 Jun 15;122(12 ):1928-36 - PubMed
  6. Nat Neurosci. 2016 Jan;19(1):28-33 - PubMed
  7. Cancer Res. 2010 Nov 1;70(21):8255-8 - PubMed
  8. Genes Chromosomes Cancer. 2007 Sep;46(9):839-51 - PubMed
  9. Expert Opin Pharmacother. 2015 Mar;16(4):573-83 - PubMed
  10. J Clin Oncol. 2007 Feb 20;25(6):682-9 - PubMed
  11. Oncotarget. 2015 Sep 15;6(27):23342-57 - PubMed
  12. J Neurol Sci. 2007 Jan 31;252(2):144-53 - PubMed
  13. J Clin Oncol. 2015 Mar 20;33(9):1015-22 - PubMed
  14. Clin Transl Med. 2015 Mar 03;4:10 - PubMed
  15. Nat Rev Cancer. 2005 Apr;5(4):275-84 - PubMed
  16. Pigment Cell Melanoma Res. 2014 Nov;27(6):1032-8 - PubMed
  17. Nat Rev Neurosci. 2011 Feb;12(2):88-104 - PubMed
  18. Int J Cancer. 2009 Jul 1;125(1):244-8 - PubMed
  19. Clin Cancer Res. 2008 Jan 1;14 (1):123-9 - PubMed
  20. J Neurosci. 2015 Feb 25;35(8):3330-45 - PubMed
  21. Clin Cancer Res. 2006 Aug 1;12(15):4687-94 - PubMed
  22. Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83 - PubMed
  23. Clin Cancer Res. 2011 Dec 15;17(24):7595-604 - PubMed
  24. Cancer Cell. 2009 Feb 3;15(2):135-47 - PubMed
  25. J Clin Oncol. 2008 Jun 10;26(17):2821-7 - PubMed
  26. Neurology. 2009 Nov 10;73(19):1526-31 - PubMed
  27. J Clin Invest. 2008 May;118(5):1739-49 - PubMed
  28. Cancer Res. 2006 Jan 1;66(1):10-3 - PubMed
  29. Cancer Res. 2010 Jan 15;70(2):512-9 - PubMed
  30. Cancer Cell. 2006 May;9(5):391-403 - PubMed
  31. Neuron. 2014 Jan 22;81(2):229-48 - PubMed
  32. Cancer Res. 2007 Apr 15;67(8):3560-4 - PubMed
  33. Methods Mol Med. 2005;111:297-322 - PubMed
  34. Cell Stem Cell. 2009 May 8;4(5):440-52 - PubMed
  35. J Clin Invest. 2011 Apr;121(4):1344-8 - PubMed
  36. PLoS One. 2008 Apr 09;3(4):e1936 - PubMed
  37. Acta Neuropathol. 2011 Mar;121(3):397-405 - PubMed
  38. J Neurooncol. 2001 Mar;52(1):63-72 - PubMed
  39. Blood. 2016 Oct 13;128(15):1918-1927 - PubMed
  40. Cancer Res. 2010 Jun 1;70(11):4274-9 - PubMed
  41. Cancer Res. 2009 Jun 1;69(11):4682-90 - PubMed
  42. Cancer Res. 2003 Sep 15;63(18):5821-8 - PubMed
  43. Nature. 2004 Nov 18;432(7015):396-401 - PubMed
  44. Invest New Drugs. 1999;17(4):343-59 - PubMed
  45. Neuro Oncol. 2011 Feb;13(2):223-34 - PubMed
  46. Mol Cancer. 2006 Dec 02;5:67 - PubMed
  47. Nature. 2006 Dec 7;444(7120):756-60 - PubMed
  48. Stem Cells. 2008 Jun;26(6):1414-24 - PubMed
  49. Acta Neuropathol. 2011 Jun;121(6):763-74 - PubMed
  50. Cancer Res. 2015 Jun 1;75(11):2349-62 - PubMed
  51. FEBS Open Bio. 2012 Jun 01;2:129-34 - PubMed
  52. Oncotarget. 2017 Jan 3;8(1):583-595 - PubMed
  53. Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):503-15 - PubMed
  54. J Neurooncol. 2016 May;128(1):47-56 - PubMed
  55. Expert Opin Pharmacother. 2016;17(7):1031-8 - PubMed

Publication Types

Grant support